ClinicalTrials.gov
public full text
Public Domain
Varenicline for Adolescent Smoking Cessation
This is a placebo-controlled smoking cessation treatment study for adolescents ages 14-21. After assessment and inclusion into the study, participants will be randomized to receive a 12-week double blind course of varenicline or placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Varenicline for Nicotine Vaping Cessation in Adolescents#969209
- Hollings Cancer Center Varenicline Sampling Study#859405
- TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol#1085795
- Treatment of Covid-19 With a Herbal Compound, Xagrotin#1104133
- Switching to E-cigarettes in Smokers Not Interested in Quitting#1057771
Record · ID 1058450
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive